Life-science briefing: Tuesday, March 18, 2008
TODAY’S HEADLINES:
Luminous Medical raises $24M for automated glucose monitoring (release)
Alimera Sciences gets $30M for eye-disease drug (release)
Vaccine maker LigoCyte draws $28M (release)
Heartbeat tracker CardioNet trims IPO, aims for listing today (IPOhome)
Axial Biotech takes in $6M for spinal diagnostics (release)
Insulin bioengineer enGene receives $6.4M (release)
GlucoLight raises… Continue Reading
Life sciences briefing: Monday, Sept. 10, 2007
Featured companies: BioVascular, Carefx, ClinResearch, Healthcare Management Directions, NanoCor, OxyPlus, Revitus, Spotlight Surgical, United BioSource
UPDATED: See below.
Healthcare IT provider Carefx pulls in $17.9M — Carefx, a Scottsdale, Ariz., provider of hardware and software that “aggregates” patient records, has raised $17.85 million in a third funding round, Private… Continue Reading
Ceregene: Catching an updraft in gene therapy
(UPDATED: See below.)
Ceregene, a San Diego biotech at work on a gene therapy for Parkinson’s disease, has so far raised $28 million in a third funding round and last week struck a development partnership with Genzyme that resulted in a $25 million up-front payment and potential… Continue Reading
Applied Genetic Technologies gets $2M for gene therapy
Applied Genetic Technologies, an Alachua, Fla., gene-therapy developer, received a $2 million milestone payment from Genzyme.
The two companies are jointly developing a gene therapy for treating a form of blindness called age-related macular degeneration. The treatment uses an adeno-associated virus designed to deliver a… Continue Reading
Intrexon picks up $25M for gene therapy
Intrexon, a Blackburg, Va., developer of engineered gene therapies it calls “transcriptional therapeutics,” raised $25 million in a third round of financing provided by Third Security. Earlier funding rounds were provided by Third Security and NewVa Capital Partners.
Intrexon is at work on drugs based on… Continue Reading